demo · 13 papers with claims · 12 for outreach · 0 old · 1 reviews
Filtered out
Abstract 245: Preclinical development of HDM2020, a novel ADC targeting FGFR2b, in gastric cancer (GC) and squamous non-
Abstract 4769: Characterization of novel humanized FGFR2b antibody-based ADCs site-specifically conjugated with topoisom
819TiP A phase I clinical study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of HDM2020 (FGFR2b-
Abstract 3778: Preclinical evaluation of BG-C137, a potential first-in-class FGFR2b-targeting ADC, for the treatment of
Brave new world—new and emerging treatments for gastric cancer
SCR-A002, a novel FGFR2b-targeting antibody-drug-conjugate for solid tumors.
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration
The Complexity and Significance of Fibroblast Growth Factor (FGF) Signaling for FGF-Targeted Cancer Therapies
Fibroblast Growth Factor Receptor 2 Signaling in Breast Cancer
Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers